Skip to main content
Equibles

RENAISSANCE TECHNOLOGIES LLC

Position in CGEM — Cullinan Therapeutics, Inc.

CIK 1037389 NEW YORK, NY
Back to CGEM Full portfolio

Position in CGEM

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$5,951,228
+$1,345,611 QoQ
Shares Held
326,811
+0.8% QoQ
Ownership
0.508%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#34
of 183 holders
Holding Since
Jun 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CGEM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. CGEM ranks #73 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EXEL
Exelixis, Inc.
 13,427,993 $730,617,099
2 CORT
Corcept Therapeutics Inc
 5,261,628 $457,498,554
3 INCY
Incyte Corp
 3,512,132 $398,135,283
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 320,008 $158,957,573
5 JAZZ
Jazz Pharmaceuticals plc
 562,073 $135,442,730
6 RPRX
Royalty Pharma plc
 1,935,800 $108,540,306
7 TVTX
Travere Therapeutics, Inc.
 1,833,079 $104,137,217
8 GMAB
Genmab A/S
 3,517,850 $96,635,339

All Filings in CGEM

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,951,228 326,811
2026-03-31 $4,605,617 324,111
2025-12-31 $6,538,157 631,706
2025-09-30 $3,139,389 529,408
2025-06-30 $2,518,973 334,525
2025-03-31 $2,747,970 363,008
2024-12-31 $2,320,387 190,508
2024-09-30 $4,717,332 281,800
2024-06-30 $7,354,587 421,708
2024-03-31 $5,471,544 321,100
2023-12-31 $2,691,056 264,088
2023-09-30 $2,015,435 222,700
2023-06-30 $2,642,656 245,600
2023-03-31 $2,447,016 239,200
2022-12-31 $3,246,235 307,700
2022-09-30 $3,874,139 302,195
2022-06-30 $3,763,952 293,600
2021-12-31 $410,438 26,600
2021-06-30 $669,036 25,982